News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Naveen Pemmaraju: Bromodomain and PLX51107 with Azacitidine in Patients with R/R Myeloid Malignancies
Naveen Pemmaraju/mdanderson.org
Mar 11, 2025, 08:03

Naveen Pemmaraju: Bromodomain and PLX51107 with Azacitidine in Patients with R/R Myeloid Malignancies

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, shared a paper he and his colleagues authored on X:

“Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies.”

Authors: Jayastu Senapati et al.

Naveen pemmaraju

cancer Courtney D. DiNardo Darla Miller Elias Jabbour Farhad Ravandi Gautam Borthakur Ghayas C. Issa Guillermo Garcia-Manero Jan Burger Jayastu Senapati Joseph D. Khoury Kapil N. Bhalla Koji Sasaki Lucia Masarova Marina Konopleva Nathaniel R. Wilson Naval Daver Naveen Pemmaraju Nicholas J. Short Nitin Jain OncoDaily Oncology Sherry Pierce Tapan Kadia Warren C. Fiskus Wei Qiao Yesid Alvarado
Special Coverage
Blog
Apr 18, 2025, 20:12
Caitríona Duggan: Delighted for the opportunity to share our work at MASCC
Blog
Apr 18, 2025, 20:03
Fumiko Ladd Chino: Honored to be invited to speak about financial toxicity
Blog
Apr 18, 2025, 20:02
Estelamari Rodriguez: ACS NLCRT Biomarker Workshop version of brainstorming with the stars
Blog
Apr 18, 2025, 19:54
Sami Mansfield: Fiber, the microbiome, and cancer care
Blog
Apr 18, 2025, 19:49
Eric K. Singhi Discusses Lung Cancer at ASCO 2025
Science
Apr 18, 2025, 19:44
Nirmala Bhoo Pathy: The need for race and ethnicity data in cancer control
Science
Apr 18, 2025, 19:28
Andreas Charalambous: Achieving digital transformation in cancer care across Europe
Blog
Apr 18, 2025, 19:26
SIOG - Older adults deserve better: Let’s close the gap in Cancer Care
Science
Apr 18, 2025, 19:10
Rafael Grochot: The safety and activity of FGFR inhibitors in early-phase clinical trials
Blog
Apr 18, 2025, 18:58
Mission Adaptation and Mission Cancer: Resilient Health Systems for Cancer - ECHoS
Blog
Apr 18, 2025, 18:55
Robert F. Kennedy Jr. visited U.S. FDA with Commissioner Martin Makary on Medical Innovation
Blog
Apr 18, 2025, 18:48
Sachin Jain: What are the pearls you’ve learned from a coach or mentor?